News
APR has successfully accomplished the certification of Nexodyn AcidOxidizing (AOS)™ as Medical Device Class III according to the European regulation

Helsinn Group Awarded Global CEO Cancer Gold Standard Accreditation

TGA Approves AKYNZEO® (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)

Cerbios has been rewarded at Swiss Venture Club Prix 2015 based on its continued Innovation and Sustainability

Helsinn Group Signs Exclusive Agreement with Mundipharma for Distribution and Licence of Anamorelin in China, Hong Kong and Macao

Improved Bioavailability through cGMP super critical fluid atomization
SFI Awarded Prestigious ABC’s Tyler Award Given Global Research Effort
Helsinn Group signs exclusive agreements with Mundipharma for distribution and licence of anamorelin in Brazil and across key markets in the Middle East and North Africa

Helsinn Group signs exclusive agreement with Mundipharma for distribution and licensing of Netupitant/Palonosetron (nepa) in Brazil

Linkedin